| Teva Pharma AG - Cedur retard, Retardtabletten | | 45352 | | 01 | | Cedur retard | | Retardtabletten | | C10AB02 | | Bezafibrat | | 22.04.1983 | | |
| | Composition | | bezafibratum 400 mg, lactosum monohydricum 51 mg, povidonum K 25, natrii laurilsulfas, hypromellosum, silica colloidalis anhydrica, Überzug: hypromellosum, acidi ethacrylici et methylis methacrylatis polymerisatum, lactosum monohydricum 3.75 mg, macrogolum 10'000, talcum, E 171, polysorbatum 80, natrii citras dihydricus, magnesii stearas, pro compresso obducto corresp. natrium 0.82 mg. | | Packungsbestandteile | | Comprimés retards | | | | | Principe actif | Concentr. |
|---|
| Bezafibrate | 400 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Bezafibrate | 400 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| | | | | | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 3.75 mg | | | Macrogol | 10000 | | | | | | | | | | | Natrii Citras Dihydricus | | | | | | | | Polysorbatum 80 | | | | | 25 | | | | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 021 | 100 Comprimé(s) | 26.84 | 45.60 | B | LS | Non | | 056 | 30 Comprimé(s) | 8.55 | 25.70 | B | LS | Non |
|
|
